GENZYME CORP Accounts Receivable, Credit Loss Expense (Reversal)
GENZYME CORP reported Accounts Receivable, Credit Loss Expense (Reversal) of $19.12 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2011-03-01
- GENZYME CORP accounts receivable, credit loss expense (reversal) for the quarter ending 2010-12-31 was $2.62M, a 36.91% decline year-over-year.
- GENZYME CORP accounts receivable, credit loss expense (reversal) for the quarter ending 2010-09-30 was $4.06M, a 4.42% increase year-over-year.
- GENZYME CORP accounts receivable, credit loss expense (reversal) for the quarter ending 2010-06-30 was $9.98M, a 97.82% increase year-over-year.
- GENZYME CORP accounts receivable, credit loss expense (reversal) for the quarter ending 2010-03-31 was $2.45M, a 57.50% decline year-over-year.
- GENZYME CORP accounts receivable, credit loss expense (reversal) for fiscal 2010 was $19.12M, a 1.38% increase from fiscal 2009.
- GENZYME CORP accounts receivable, credit loss expense (reversal) for fiscal 2009 was $18.86M, a 45.24% increase from fiscal 2008.
- GENZYME CORP accounts receivable, credit loss expense (reversal) for fiscal 2008 was $12.98M.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2010-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $6.69M derived: sum of 2 quarters · filed 2011-03-01 | $16.67M derived: sum of 3 quarters · filed 2011-03-01 | $19.12M 10-K · filed 2011-03-01 |
| 2010-09-30 | $4.06M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | $14.05M derived: sum of 2 quarters · filed 2010-11-09 | $16.50M 10-Q · filed 2010-11-09 | $20.65M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-06-30 | $9.98M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | $12.43M 10-Q/A · filed 2010-09-07 | $16.59M derived: sum of 3 quarters · filed 2011-03-01 | $20.48M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-03-31 | $2.45M 10-Q/A · filed 2010-05-11 | $6.61M derived: sum of 2 quarters · filed 2011-03-01 | $10.50M derived: sum of 3 quarters · filed 2011-03-01 | $15.54M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $8.05M derived: sum of 2 quarters · filed 2011-03-01 | $13.09M derived: sum of 3 quarters · filed 2011-03-01 | $18.86M 10-K · filed 2011-03-01 |
| 2009-09-30 | $3.89M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | $8.94M derived: sum of 2 quarters · filed 2010-11-09 | $14.70M 10-Q · filed 2010-11-09 | $18.62M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-06-30 | $5.05M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | $10.81M 10-Q/A · filed 2010-09-07 | $14.73M derived: sum of 3 quarters · filed 2011-03-01 | $17.95M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-03-31 | $5.76M 10-Q/A · filed 2010-05-11 | $9.68M derived: sum of 2 quarters · filed 2011-03-01 | $12.90M derived: sum of 3 quarters · filed 2011-03-01 | |
| 2008-12-31 | $3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $7.14M derived: sum of 2 quarters · filed 2011-03-01 | $12.98M 10-K · filed 2011-03-01 | |
| 2008-09-30 | $3.22M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-11-02 | $9.06M 10-Q · filed 2009-11-02 | ||
| 2008-06-30 | $5.84M 10-Q/A · filed 2009-09-04 | |||
| 2007-12-31 | $9.66M 8-K · filed 2010-06-14 |